Bordes; Marie-Francoise

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bordes; Marie-Francoise.The latest application filed is for "novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same".

Company Profile

0.8.6

Bordes; Marie-Francoise - Labarthe sur Leze N/A FR
Bordes; Marie-Francoise - Toulouse FR
Bordes; Marie-Francoise - Labarthe sur Seze FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Grant 8,633,216 - Alcouffe , et al. January 21, 2	2014-01-21
Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis Grant 8,034,828 - Badorc , et al. October 11, 2	2011-10-11
Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same Grant 8,008,321 - Alcouffe , et al. August 30, 2	2011-08-30
Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same App 20110136856 - ALCOUFFE; Chantal ; et al.	2011-06-09
1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for preparing them and pharmaceutical compositions containing them Grant 7,803,811 - Badorc , et al. September 28, 2	2010-09-28
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives Grant 7,553,845 - Alcouffe , et al. June 30, 2	2009-06-30
Use Of Fgf Inhibiting Substituted 1,2,3 Indolizine Derivatives In The Preparation Of Medicaments Which Can Be Used To Treat Diseases Linked To Pathological Choroidal Angiogenesis App 20090030034 - BADORC; Alain ; et al.	2009-01-29
Novel 1,2,3-Substituted Indolizine Derivatives, Inhibitors of FGFs, Method for Preparing Them and Pharmaceutical Compositions Containing Them App 20090023770 - BADORC; Alain ; et al.	2009-01-22
1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same Grant 7,442,708 - Badorc , et al. October 28, 2	2008-10-28
Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same App 20080108648 - ALCOUFFE; Chantal ; et al.	2008-05-08
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives App 20060199962 - Alcouffe; Chantal ; et al.	2006-09-07
Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same App 20050203126 - Badorc, Alain ; et al.	2005-09-15
Derivatives of 2-hydroxythiophene and -furan fused with a nitrogen-containing ring and their application in therapy Grant 5,190,938 - Badorc , et al. March 2, 1	1993-03-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.